| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $1.35B | $807.83M | $595.27M | $608.18M | $27.11M |
| Cost of Revenue | $2.61B | $1.73B | $1.94B | $1.65B | $154.90M |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $1.21B | $1.18B | $937.01M | $821.51M | $750.18M |
| SG&A | $1.03B | $900.95M | $797.24M | $734.57M | $652.48M |
| Operating Income | -$3.50B | -$3.02B | -$3.10B | -$2.59B | -$1.53B |
| Interest Expense | – | – | $24.91M | $30.60M | $1.37M |
| Tax Expense | -$2.33M | $1.20M | $1.03M | $379.00K | $49.00K |
| Net Income | -$2.70B | -$2.71B | -$2.83B | -$1.30B | -$2.58B |
| EPS (basic) | -11.8100 | -1.2500 | -1.3600 | -0.7800 | -6.4100 |
| EPS (diluted) | -12.0900 | -1.2500 | -1.3600 | -1.5100 | -6.4100 |
| Shares (diluted) | $313.40M | $2.45B | $2.08B | $1.69B | $740.39M |